Publication Name	World Journal of Clinical Urology
Manuscript ID	36910
Country	Australia

Received	2017-10-29 03:28
Peer-Review Started	2017-10-29 04:28
To Make the First Decision	2017-11-30 01:18
Return for Revision	2017-12-01 01:10
Revised	2017-12-08 03:50
Second Decision	2017-12-14 10:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-12-28 19:35
Articles in Press	2017-12-28 19:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-03-13 04:28
Publish the Manuscript Online	2018-03-16 05:58

ISSN	2219-2816 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Minireviews
Article Title	Neutrophil-lymphocyte ratio in the management and prediction of outcomes in renal cell carcinoma
Manuscript Source	Invited Manuscript
All Author List	Tuck Y Yong and Kareeann SF Khow
ORCID	Author(s) ORCID Number Tuck Y Yong http://orcid.org/0000-0002-8026-7498 Kareeann SF Khow http://orcid.org/0000-0003-3960-1025
Funding Agency and Grant Number
Corresponding Author	Tuck Y Yong, FRACP, Doctor, Internal Medicine, Flinders Private Hospital, Flinders Drive, Bedford Park, South Australia 5042, Australia. tyyong@hotmail.com
Key Words	Neutrophil-lymphocyte ratio; Prognosis; Renal cell carcinoma; Survival
Core Tip	Neutrophil-lymphocyte ratio (NLR) is a simple and inexpensive inflammatory marker that is useful in the assessment of patients with renal cell carcinoma (RCC). An elevated pretreatment NLR has been found to be associated with reduced overall, recurrence-free and progress-free survival as well as risk of recurrence in localized RCC. In addition, a lower pretreatment NLR has been demonstrated to be associated with better clinical response to systemic therapy. NLR is a promising marker for risk stratification in RCC and guiding treatment choices.
Publish Date	2018-03-16 05:58
Citation	Yong TY, Khow KSF. Neutrophil-lymphocyte ratio in the management and prediction of outcomes in renal cell carcinoma. World J Clin Urol 2018; 7(1): 1-6
URL	http://www.wjgnet.com/2219-2816/full/7/i1/1.htm
DOI	http://dx.doi.org/10.5410/wjcu.v7.i1.1

Full Article (PDF)	WJCU-7-1.pdf
Full Article (Word)	WJCU-7-1.doc
Manuscript File	36910-Review.docx
Answering Reviewers	36910-Answering reviewers.pdf
Audio Core Tip	36910-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	36910-Conflict-of-interest statement.pdf
Copyright License Agreement	36910-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	36910-Language certificate.pdf
Peer-review Report	36910-Peer-review(s).pdf
Scientific Misconduct Check	36910-Scientific misconduct check.pdf
Scientific Editor Work List	36910-Scientific editor work list.pdf